Inspection Record

Kuehne + Nagel Ltd. — Health Canada Inspection Findings

Health CanadaInspected 2022-05-10 5 findingsDeviation, CAPA, and investigationOther quality systemTraining and personnel

View the regulator's official source The source document is always the basis for judgement.

Findings

1Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

2Other quality system

The assessment, documentation, and/or procedures for considering the resale of returned drugs were inadequate.

3Other quality system

The handling of standard operating procedures for good manufacturing practices was inadequate.

4Training and personnel

The job descriptions for personnel, the authority given to personnel, and/or the delegation of duties was inadequate and/or undocumented.

5Other quality system

The implementation of a self-inspection program was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-05-10. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Kuehne + Nagel Ltd. company profile — full history Health Canada documents, 2022 Go to Findings search